RP-6306 in Patients With Advanced Cancer

Clinical trial NCT05605509 · COMPLETED

Trial details

NCT number: NCT05605509
Sponsor: Canadian Cancer Trials Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2023-05-24
Primary completion: 2025-11-14
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.